Floridienne reported, without giving exact numbers, 1Q25 sales growth driven by the exceptional momentum of Biotrop. recording a significant increase in both revenue and profitability thanks to the success of its biological solutions for open-field crops in the Brazilian market. At the same time BioFirst (previously known as BioBest) saw increased competition in North America in the greenhouse cultivation segment, impacting the profitability of its legacy activities. We maintain our € 835 TP and...
This morning, Avantium announced it has been awarded a EUR200k grant by the EU Horizon Europe programme to participate in the CERISEA consortium, led by Michelin Engineered Polymers, which aims to build and operate a 5-Hydroxymethylfurfural (5-HMF) flagship plant. This 3Kt/year industrial demo plan
Yesterday, following unanimous approval of a 1:10 reverse stock split by the Board on 14th May, Avantium began trading on a post-reverse stock split basis. As a result of the reverse stock split, shareholders have been allotted one new ordinary share with a par value of EUR1.00 for every 10 existin
This morning, Avantium announced it has joined the Bottle Collective as a technical partner to support the development and scale-up of Dry Molded Fiber (DMF) bottles. This industrial technology stands as a next-generation solution to produce sustainable packaging at scale, converting renewable plan
Yesterday, Avantium announced the successful development of a PEF-based spacer fabric in collaboration with partners Auping, Muller Textiles, Antex and Monosuisse. This breathable, cushioning 3D material marks a step forward for this partnership, ongoing since 2024, aiming to create PEF-based yarns
We keep our HOLD and €12.5 target price on Sligro. We continue to view the equity story as a margin recovery play but note that improvements in FY25F should be more modest than previously expected due to the ongoing difficult macroeconomic environment. We cut our Adj. EBITDA forecasts by 7% and 11% for FY25F and 2026F. Sligro's balance sheet offers limited room for inorganic growth or for more cash return to shareholders, the group leverage ratio standing at 3.4x NFD/EBITDA at the end of 2024. S...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.